Historical record - last NADAC publication: 4/17/2024
Product Information
ROPINIROLE HCL 5 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0826 per EA under NDC 16729023801. Its NADAC has been published 288 times since Nov 14, 2018.
Strength
5 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729023801
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/17/2024
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204022On Market Since
10/17/2018
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL 5 MG TABLET has been published 288 times since Nov 14, 2018, and over the history we have for it it has declined 31.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0826 per EA |
|---|---|
| All-time high | $0.1401 (Dec 11, 2019) |
| All-time low | $0.0772 (Feb 20, 2019) |
| Median price | $0.1080 |
| Average price | $0.1081 |
| Largest weekly change | +51.8% (Dec 20, 2023) |
| Weeks tracked | 288 |
| Tracking since | Nov 14, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 5 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0826 per EA (NDC 16729023801), effective May 15, 2024.
How has the price of ROPINIROLE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL 5 MG TABLET has declined 31.6%. It has been tracked across 288 weekly CMS publications since Nov 14, 2018.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 5 MG TABLET?
Since Nov 14, 2018, the NADAC for ROPINIROLE HCL 5 MG TABLET has ranged from a low of $0.0772 (Feb 20, 2019) to a high of $0.1401 (Dec 11, 2019), with a median of $0.1080 per EA.
Are there cheaper alternatives to ROPINIROLE HCL 5 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, ROPINIROLE HCL 5 MG TABLET, is $0.0766 per EA — about 7% below ROPINIROLE HCL 5 MG TABLET.
Who manufactures ROPINIROLE HCL 5 MG TABLET?
ROPINIROLE HCL 5 MG TABLET (NDC 16729023801) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification